A detailed history of Gkv Capital Management Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 130 shares of LLY stock, worth $100,183. This represents 0.09% of its overall portfolio holdings.

Number of Shares
130
Previous 15,462 99.16%
Holding current value
$100,183
Previous $11.9 Billion 99.1%
% of portfolio
0.09%
Previous 4.87%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$725.72 - $929.72 $10.8 Million - $13.8 Million
14,824 Added 11403.08%
14,954 $12.4 Billion
Q1 2025

May 12, 2025

SELL
$725.72 - $929.72 $11.1 Million - $14.3 Million
-15,332 Reduced 99.16%
130 $107 Million
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $11.2 Million - $14.4 Million
15,462 New
15,462 $11.9 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $732B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gkv Capital Management Co., Inc. Portfolio

Follow Gkv Capital Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gkv Capital Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gkv Capital Management Co., Inc. with notifications on news.